ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko03010	Ribosome	53/146	129/7206	9.92226890756e-59
ko03050	Proteasome	15/146	54/7206	8.47454239156e-14
ko00190	Oxidative phosphorylation	15/146	127/7206	3.23156463535e-08
ko05012	Parkinson's disease	14/146	155/7206	2.62714413126e-06
ko04932	Non-alcoholic fatty liver disease (NAFLD)	14/146	182/7206	1.70636694318e-05
ko05016	Huntington's disease	15/146	215/7206	2.70421830624e-05
ko05010	Alzheimer's disease	14/146	202/7206	5.46482887966e-05
ko03013	RNA transport	12/146	166/7206	0.000127516356679
ko00970	Aminoacyl-tRNA biosynthesis	6/146	44/7206	0.000233520245283
ko03008	Ribosome biogenesis in eukaryotes	7/146	79/7206	0.00104035460443
ko04260	Cardiac muscle contraction	7/146	98/7206	0.00361023820657
ko05200	Pathways in cancer	2/146	492/7206	0.00416680190424
ko05169	Epstein-Barr virus infection	10/146	206/7206	0.00885589147896
ko00623	Toluene degradation	1/146	1/7206	0.0202608936998
ko00361	Chlorocyclohexane and chlorobenzene degradation	1/146	1/7206	0.0202608936998
ko00364	Fluorobenzoate degradation	1/146	1/7206	0.0202608936998
ko04151	PI3K-Akt signaling pathway	2/146	390/7206	0.0246788421236
ko05205	Proteoglycans in cancer	1/146	271/7206	0.045278339431
ko04014	Ras signaling pathway	1/146	279/7206	0.0465186064228